Clayton Smith
Manchester University NHS Foundation Trust · OncoVerity, Inc. · CMFT
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Clayton Smith as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:55 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04715347 · Interstitial Lung Disease Within a Lung Cancer ScreeningManchester University NHS Foundation Trust · completed · Interstitial Lung Disease · principal investigator
- Ph1NCT04150887 · Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid LeukemiaOncoVerity, Inc. · active not recruiting · Leukemia, Myeloid, Acute · study director
- Ph2NCT04023526 · A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive ChemotherapyOncoVerity, Inc. · active not recruiting · Leukemia, Myeloid, Acute · study director
- N/ANCT02227381 · Action Medical ResearchManchester University NHS Foundation Trust · completed · Learning Disabilities · principal investigator
- Ph1NCT00003435 · Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic CancerDuke University · withdrawn · Leukemia, Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- HIV RIBOZYMES IN UCB STEM CELLSP01AI040981 · NIAID · DUKE UNIVERSITY · fiscal years 1997 to 2000 · $126,223 awarded in 2000Same name and institution; not confirmed by an ID
- CORE--GENE THERAPYP30AI028662 · NIAID · DUKE UNIVERSITY · fiscal years 1994 to 1999 · $85,264 awarded in 1999Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:55 UTC. The ranking covers the 200 most relevant of 911 PubMed records, and a shared surname and initials can bring in a namesake. All 911 on PubMed
- Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.N Engl J Med · 20105,909 citationsRCR 183.4
- 5,255 citationsRCR 172.8
- Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.N Engl J Med · 20164,171 citationsRCR 179.0
- Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.N Engl J Med · 20194,045 citationsRCR 220.2
- B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.N Engl J Med · 20081,949 citationsRCR 45.2
- Two-year outcomes after transcatheter or surgical aortic-valve replacement.N Engl J Med · 20121,900 citationsRCR 67.1
- Strategies for multivessel revascularization in patients with diabetes.N Engl J Med · 20121,461 citationsRCR 44.5
- 1,426 citationsRCR 54.2
- 1,162 citationsRCR 30.5
- 1,101 citationsRCR 35.7